MYO - Myomo, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD

Myomo, Inc.

One Broadway
14th Floor
Cambridge, MA 02142
United States

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Paul R. GudonisChairman, CEO & PresN/AN/A1955
Ms. Davie Mendelsohn RNVP of Sales & Clinical ServicesN/AN/A1954
Mr. Jonathan Naft CPOVP & GMN/AN/A1965
Mr. Ralph A. GoldwasserCFO & Principal Accounting OfficerN/AN/A1948
Mr. Clifford J. ConneightonChief Marketing OfficerN/AN/A1950
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Myomo, Inc., a commercial stage medical robotics Company, provides expanded mobility solutions for patients suffering from neurological disorders and upper limb paralysis in the United States. The company develops and markets MyoPro, a myoelectric elbow/wrist/hand orthosis that supports an impaired hands and arms of individuals due to a brachial plexus injury, stroke, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, and other upper limb neuromuscular deficits. Myomo, Inc. and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.